Beta-lactam containing regimen for the shortening of Buruli ulcer disease therapy: comparison of 8 weeks standard therapy (rifampicin plus clarithromycin) vs. 4 weeks standard plus amoxicillin/clavulanate therapy [RC8 vs. RCA4].

Actual value of the grant is 507,601.00 GBP. Budget associated to ARAID is 143450 GBP. Amount in EUR are estimates.

Acronym: 
BLMs4BU
Author: 
Ramón García, Santiago
Principal researcher: 
Santiago Ramón Garcia
Managing entity: 
ARAID
Scope: 
Internacional
Entidades participantes: 
Fundación ARAID, Spain
Fondation Raoul Follereau, France
University Aomey-Calavi, Benin
Instituto de Salud Carlos III
Fundación Anesvad
Number of researchers: 
20
Start date: 
06/2020
End date: 
06/2023
Entidad financiadora
Financing entity: 
Tres Cantos Open Lab Foundation
Presupuesto
Total budget: 
540.000€